ESR1 and breast cancer: Upon estrogen induction, Scrib level increases and Scrib recruits another amino acid transporter, SCL7A3, to form a quaternary complex with SCL7A5 and LGL2 and promote resistance to Tamoxifen in ER+ breast cancer (Saito et al., 2022).